ENDRA Life Sciences- Warrants (12/05/2022) Other Current Liabilities

As of the most recent data (March 2026), NDRAW shows a other current liabilities of $700K. That compares with $440K in the prior-year period — up 59.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRAW's other current liabilities is now $700K (was $440K) — a 59.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences- Warrants (12/05/2022) is outperforming or lagging.

Tracking NDRAW's other current liabilities over time shows whether ENDRA Life Sciences- Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $700K That compares with $440K in the prior-year period — up 59.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has ENDRA Life Sciences- Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $700K) with ownership activity and broader fundamentals.

ENDRA Life Sciences- Warrants (12/05/2022)'s other current liabilities is $700K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.